e aim of this study was to evaluate the levels of malondialdehyde as an oxidative stress marker in the same hemodialysis patients a�er changing the quality of dialysate with ultrapure dialysis �uid. Methods. is prospective study concerns hemodialysis patients; all patients were in the �rst step treated with conventional dialysate, and in the second step (three months later) the same patients were treated with online produced ultrapure dialysis �uid. e malondialdehyde, C-reactive protein, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, �brinogen, and albumin were quanti�ed before the two steps. Results. irty-seven patients completed the study. �ltrapure dialysis �uid reduced but not signi�cantly the malondialdehyde concentrations. �oth dialysis �uids were associated with improvement in the malondialdehyde level before and a�er the hemodialysis session. In lipid parameters, there was a signi�cant decrease with conventional dialysis �uid versus ultrapure dialysis �uid of triglycerides, total cholesterol, and high-density lipoprotein in patients� blood. Instead, the level of low-density lipoprotein, �brinogen, albumin, and Creactive protein does not change signi�cantly. Conclusion. e lipid parameters were improved for triglycerides and total cholesterol. Malondialdehyde increases following the hemodialysis session, and the conventional dialysate increased malondialdehyde levels more than the ultrapure dialysis but the di�erences were not statistically signi�cant.
Introduction
e chlorine compounds used to suppress bacterial growth in the potable water supply are removed when the water is treated for hemodialysis. It is almost impossible to completely prevent bacterial proliferation in the treated water and the dialysate. As a result, even though conventional dialysate meets the required quality standards, it usually contains some low level of microbiological contamination, including fragments of endotoxin and peptidoglycans and bacterial fragments [1] [2] [3] . ese contaminants, sometimes collectively referred to as "cytokine-inducing substances, " cross both low-�ux and high-�ux hemodialysis membranes [2, 4] and stimulate cytokine production by in�ammatory cells [5] . e use of dialysate of much higher microbiological purity improved this state of in�ammation [6, 7] . General markers of in�ammation such as serum C-reactive protein (CRP), ferritin, or �brinogen are commonly used, but the oxidative stress referred to excessive production of reactive oxygen species (ROS) and inadequate antioxidant protection, is more sensitive, speci�c, and precocious of in�ammation state. is condition leads to structural and/or functional deterioration in cell components including DNA, proteins, carbohydrates, and lipids [8] . e presence of ROS can cause damage in many molecules, such as lipids, leading to the production of malondialdehyde (MDA), an indicator of lipid peroxidation [9] [10] [11] . In chronic renal failure (CRF) patients under hemodialysis (HD) treatment, the formation of ROS is ampli�ed, therefore beyond uremic toxins [12, 13] . e aim of this study was to evaluate the oxidative stress using 2 ISRN Nephrology quanti�cation of MDA in the CRF patients aer changing quality of dialysate with ultrapure dialysis �uid.
Materials and Methods
Concerned patients were with end-stage renal disease (ESRD) on maintenance hemodialysis. Inclusion criteria were hemodialysis patients for at least 6 months. Exclusion criteria were (i) chronic infection; (ii) chronic in�ammatory disorders; (iii) primary or secondary hyperlipidemia (other than uremic); (iv) major comorbid conditions such as severe heart failure, severe chronic obstructive lung disease, liver cirrhosis, or malignancy; and (v) unwillingness to participate in the study.
Study
Design. is prospective unicenter study was conducted according to the principles of the Declaration of Helsinki and was approved by the local Ethical Committee from the Faculty of Medicine and Pharmacy in Rabat, Morocco.
Patients were in the �rst step treated with conventional dialysate (double osmosis, deionization, and carbon �ltra-tion); in the second step (three months later) they were treated with online produced ultrapure dialysis �uid (Diasafe and heat disinfection with hotfeed Fresenius Medical Care, with reverse osmosis, deionization, and carbon �ltration) during three months. Before starting, we analyzed the microbiological quality of dialysis �uid in the two water treatments. Hemodialysis sessions were performed with the same condition using bicarbonate as a buffer. All patients received single-use biocompatible synthetic low-�ux membranes (Polyamide, Poly�ux Renal Products Gambro). Blood �ow rates were chosen between 300 and 350 mL/min, and ultra�ltration rates were set according to individual needs. Dialysate �ow rate was �xed at 500 mL/min. In all the patients, the vascular access was arteriovenous �stula. For all treatments, heparinization of the individual patient did not differ throughout the study period. Hemodialysis was prescribed and monitored using a single pool urea kinetic model to ensure a delivered dialysis dose of at least 1.2 per dialysis for thrice weekly sessions.
Study Parameters

Blood Sample.
For MDA analysis, samples were collected in EDTA-containing tubes just before commencing dialysis (pre-HD) and at the termination of dialysis procedure (post-HD). Blood venous samples (10 mL) were centrifuged at 1500 ×g for 10 min just aer being collected. e resulting plasma samples were frozen at −80 ∘ C until analysis. Serums were used to perform analysis of CRP, total cholesterol, TG, high-density lipoprotein (HDL), low-density lipoprotein (LDL), �brinogen, and albumin before the two steps.
Microbiological Quality of Dialysis Fluid.
Sample volumes were 500 mL for both puri�ed water and ultrapure dialysis �uid. We applied a membrane �ltration technique for the ultrapure dialysis �uid cultures, using a micro�lter with pore size 45 m (22-45). Tryptone glucose extract agar media were used for bacterial culture. Limulus amebocyte lysate (LAL) assay was used for determination of endotoxins (chromogenic method) according to the manufacturer [14] .
Physiological Parameters.
Serum total cholesterol, triglyceride, HDL, LDL, and CRP levels were determined using Dimension RXL Analyser (Dade Behring, Inc). MDA was determined by iobarbituric Acid Reactive Substances (TBARS) method. All chemicals and reagents used (from Merck) were of analytical grade, and Milli-Q water was used for each dilution. e analysis was performed according to published procedures for preparing MDA adduct [15, 16] . Brie�y, a plasma sample (100 L) was mixed to 300 L of a 42 mM thiobarbituric acid (42 mM) solution and 700 L of a phosphoric acid solution (1%). e whole volume was incubated in a water bath at 95 ∘ C for 45 minutes. e reaction was then stopped at ice cold temperature, and an equal volume of n-Butanol was added to the reaction mixture. Samples were then centrifuged and an aliquot of the supernatant was read at 532 nm. A calibration curve was prepared with TEP (1,1,3,3-tetramethoxypropane) as standard MDA of 0.38 up to 100 mol/L. A linear regression between TEP concentration and absorbance was constructed using the Microso Excel soware for Widows, and the regression equation was used to calculate the MDA concentration in each sample. In our study, we have taken into account only the calibration curves which had a coefficient of determination (
2 ) more than 0.99 ( Figure 1 ). Repeatability was con�rmed by corresponding coefficient of variation of 4.11%. Recovery values of 97% indicated adequate accuracy of the method. During the measurement, each sample was analyzed in duplicate. ese analyses were performed on the same patients in similar conditions and manner when using conventional dialysate and three months later aer switching to ultrapure dialysate. 
Statistical
Results
irty-nine patients were screening, and thirty-seven completed the study. Two patients were excluded for chronic in�ammatory (one had malignancy disease, and the other had chronic infection on his foot). ey were in hemodialysis for at least 24 months. e characteristics of these patients are given in Table 1 . Nineteen males and eighteen females were with mean age of 50.7 ± 16.55 years. e causes of ESRD were diabetic nephropathy (15%), chronic glomerulonephritis (20%), chronic interstitial nephritis (17.5%), and unknown (32.5%). e microbiological parameters of dialysis �uid in the two water treatments of our center are presented in Table  2 . Blood lipid analyses of patients were performed before and three months aer that switching from conventional to ultrapure dialysis �uid. �ur data show signi�cant changes in blood lipid have occurred upon the above switching (Table  3) . ere was a signi�cant decrease of TG (1.38 ± 0.62 versus 1.13 ± 0.37; 0.006), total cholesterol (1.72 ± 0.44 versus 1.38±0.13; 0.001), and HDL (0.39±0.10 versus 0.32±0.12; 0.02) in patients' blood. Instead, the level of LDL, �brinogen, albumin, and CRP did not change signi�cantly.
e use of ultrapure dialysis �uid reduced but not signi�cantly the oxidative stress as evidenced by reduction in MDA concentrations (Tables 4 and 5 ). Both dialysis �uids were associated with improvement of the MDA level MDA2 ( Mol/L) aer hemodialysis session 13.0 ± 6.5 10.9 ± 3.5 0.10 MDA difference (MDA2-MDA1) 4.6 ± 6.4 2.9 ± 2.9 0.2 before and aer HD session with < 0.001 (Table 4 ). In multivariate study we found no statistically signi�cant correlation between the value of MDA and other parameters (CRP, TG, total Cholesterol, LDL, HDL, �brinogen, and albumin). We found also that causes of ESRD did not affect changes in values of MDA.
Discussion
In this study, we con�rm that MDA increases in blood's patient following HD session, and we found that the conventional dialysate increased MDA levels more than ultrapure dialysate but the differences were not statistically signi�cant. In multivariate study, it was shown that the MDA is a good marker for assessing oxidative stress generated by the water quality in HD because there is no in�uence of other in�ammatory parameters. Effectively the European Best Practice Guidelines for Hemodialysis set the maximum allowable level for bacteria and endotoxin concentrations at 100 CFU/mL and 0.25 EU/mL, respectively [17] . For ultrapure dialysate, it is commonly de�ned as having a bacterial count less than 100 CFU/L and an endotoxin content less than 0.03 sEU/mL measured by the Limulus amebocyte lysate assay [18] . Our microbiological parameters of dialysis �uid were in agreement with these guidelines. HD patients are particularly vulnerable to contaminants in the water used to prepare concentrate and dialysate or in water used for reprocessing dialyzers. Compared to healthy individuals, HD patients are exposed to extremely large volumes of water having inadequate barriers to such toxins and cannot easily eliminate contaminants. e estimated water intake of a healthy individual is 2 liters per day or 14 liters per week. By comparison, HD patients may be exposed to 350 to 500 liters of water per week, depending on their treatment time and dialysate �ow rate [19, 20] . With normal individuals, the gastrointestinal tract separates blood from contaminants in the water. By comparison, the barrier between blood and water in HD patients is a thin membrane through which the transfer of contaminants is limited only by the size of the contaminant. Schi� and Lang demonstrate that in�am-mation, oxidative stress, and dyslipidemia are biologically linked [21] . is relation exists also in our study. On the other hand, the ultrapure dialysis �uid is associated with an improved cardiovascular risk factor pro�le [21] . is is the limit of our work since it is of short duration, which does not allow us to assess the impact of cardiovascular long term.e use of ultrapure dialysate produces a lesser degree of oxidative stress [22] . e lipid peroxidation is hallmark of oxidative stress, which disrupts the structural integrity of cell membranes and can also lead to the formation of aldehydes, which in turn by time damage lipids, proteins, and nucleic acid [23] . In addition, this state is involved in many pathophysiological processes, particularly within accelerated atherosclerosis, which is, at least in part, resistant to conventional pharmacotherapy [24] , in�ammation, and cancer [25, 26] . Switching from conventional dialysis �uid to ultrapure dialysis �uid has been shown repeatedly to be associated with a decrease in the circulating concentrations of biomarkers of in�ammation [27, 28] . But not all studies report a reduction in in�ammatory markers aer the introduction of ultrapure dialysate [29, 30] . ere are clearly many stimuli to in�ammation in hemodialysis patients, such as the presence of synthetic gras for blood access and the practice of dialyzer reuse. us, a failure to �nd a reduction in the level of in�ammatory markers with ultrapure dialysate may re�ect the presence of multiple in�ammatory stimuli. Guo et al. �nd that contaminants in the bicarbonate and salt mixture used for preparation of dialysate are important factors for increased apoptosis in monocyte-like cell; in this study, the authors provide evidence of the association between an increased monocyte apoptosis rate and impurity of dialysate [31] . e oxidative stress could play a key role in this increased apoptosis rate as it participates in both the initiation and maintenance of the apoptotic process in monocytes stimulated by oxidants and proin�ammatory cytokines [32] . Valentini et al. suggest that MDA levels suffer in�uence room time of HD treatment, as shown in our data.
Conclusion
�uanti�cation of MDA allowed us to evaluate oxidative stress in hemodialysis patient. In this study, the lipid parameters were improved for TG and total cholesterol. We con�rm that MDA increases in blood's patient following hemodialysis session on one hand and on the other hand we found that the conventional dialysate increased MDA levels more than ultrapure dialysis but the differences were not statistically signi�cant.
